<DOC>
	<DOCNO>NCT02166008</DOCNO>
	<brief_summary>- Primary objective : To evaluate efficacy Rapamide peptic ulcer prevention patient take dual antiplatelet agent - Study Design : Single center , double-blind , randomized-control trial study - Study drug : Repamipide vs. placebo - Assessment criterion The patient discharge study one following occur , 1 . Peptic ulcer upper endoscopy 3 6 month follow 2 . Clinical upper gastrointestinal bleeding peptic ulcer upper endoscopy 3 . Anemia CBC 1,3 ,6,12 month peptic ulcer upper endoscopy 4 . Evidence recurrent myocardial infarction stent thrombosis</brief_summary>
	<brief_title>Cytoprotective Agent Peptic Ulcer Dual Antiplatelet : RCT</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<criteria>1 . Age 1870 yearold 2 . Had cardiovascular disease need clopidogrel aspirin 3 . Stable enough gastroscopy 1 . Gastroscopy reveal peptic ulcer 2 . Had contraindication gastroscopy 3 . Not allow gastroscopy cardiologist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Repamipide</keyword>
	<keyword>Dual antiplatelet</keyword>
	<keyword>Peptic ulcer</keyword>
</DOC>